Adverse Drug Events

By now it is not a surprise, more and more EMR and EHR  business owners and general managers are turning to Lexicomp to solve their drug information needs.   In a few short years,  Lexicomp has been the fastest growing provider of drug information to the EMR market.   This didn't happen by accident.  It came as a result of  Lexicomp's three-legged trifecta approach to providing drug information to EMR and EHR developers -- of any size!  

What are three aspects?

1. Top quality data
2. Elegant data structure with easy to use API's
3. The best customer and development support you can find anywhere.  (It makes your work so much easier)

In addition to supplying the expected information such as drug-drug and drug-allergy interactions, adverse drug events, RxNorm mapping, generic drug lists, drug nomenclature, and more.  Lexi-Data also offers an incredibly easy to use data structure and APIs!  Although, perhaps more importantly,  Lexicomp is unparalleled in its customer service and providing assistance in the development process. If you are developing a new EMR and need a drug information supplier, make sure that Lexi is on your list.

 

And if you are thinking about building your own ePrescribing module,  I call your attention to a posting my colleague Matt Bennardo published last week:

As EHR vendors find their products growing and signing up more users, many start to think about moving from using a third-party eprescribing solution to building their own. The reasons for making this switch are many:

• As your user base grows, eprescribing fees grow too
• Bring features in-house makes it easier to respond to specific customer needs
• A third-party solution is a risk, as you never can be sure what will happen in the market

One of the first steps in building your own eprescriber is to find a data provider who can supply you with medication lists and other information that Surescripts requires to certify your tool. Lexicomp is one such provider. They've been focused on providing drug data direct to clinicians for over thirty years, but now they can also supply you with database-ready information to power an eprescriber.

Lexicomp's customers have used their data to certify EMRs and EHRs with ONC testing bodies like Drummond, CCHIT, and Infogard. Their customers have also certified eprescribers using Lexicomp data with Surescripts. And best of all, Lexicomp's flexible pricing and easy implementation allows firms of all sizes to get up and running smoothly and quickly.

 

Recently someone asked, "What would you say are the most common words that people  associate with Lexi-Data and the value and service that the product delivers?".   I would say it is a long list,  but the following short list comes to mind:  "drug interaction database , drug nomenclature,  drug reference pediatric , drug classifications list, pediatric dosage database, adverse drug events, drug interaction database for EHRs."

Apparently there has been some interest in several of my recent blog posts,  so I am re-posting two of them.  I like the second one :

The first one:

"In a few short years,  Lexicomp has gone from being the provider of choice for drug reference information to the vendor of choice for EMR development companies looking for a supplier of drug data to include in their product.   Lexi-Data provides all of the standard drug information that one would expect from the other suppliers,  but it also provides the best pediatric dosing information available.   In addition to supplying the expected information such as drug-drug and drug-allergy interactions,  adverse drug events,  RxNorm mapping,  generic drug lists,  drug nomenclature,  and more.  Lexi-Data offers an incredibly easy to use data structure and API's and most importantly,  Lexicomp is unparalleled in its customer service and providing assistance in the development process. If you are developing a new EMR and need a drug information supplier, make sure that Lexi is on your list."

The second:  (enjoy)

"We live in a turbulent and fast changing world.  What was good yesterday is not necessarily what is best for today.   Where is Netscape?   How about Alta Vista?    Lotus is certainly history but how many of you remember Multiplan and before that VisiCalc?  The changes occur quickly -- not like the phasing out of a buggy whip.  

The same could  be said about more and more EMR developers who are turning to Lexi-Data for their drug information.    Lexi-Data just hit the scene a little more than two years ago.  And how quickly it has grown and capturing a major part of new EMR development in need of drug information.  Why so?

Is it about drug information quality?   Is it about ease of integrating the APIs?   How about quality of the Pediatric Drug Information and drug-drug and drug-allergy interactions?  Or is about the top quality customer support during the development and integration phase,  where Lexicomp treats it customers like true partners?"

Needless to say,  as you can imagine,  it is about all of the above.   If you haven't acted yet,  it is about time

By now it is not a surprise,  more and more EMR and EHR  business owners and general managers are turning to Lexicomp to solve their drug information needs.   In a few short years,  Lexicomp has been the fastest growing provider of drug information to the EMR market.   This didn't happen by accident.  It came as a result of  Lexicomp's three-legged trifecta approach to providing drug information to EMR and EHR developers -- of any size!  

What are three aspects?

1. Top quality data
2. Elegant data structure with easy to use API's
3. The best customer and development support you can find anywhere.  (It makes you work so much easier)

 

In addition to supplying the expected information such as drug-drug and drug-allergy interactions, adverse drug events, RxNorm mapping, generic drug lists, drug nomenclature, and more.. Lexi-Data also offers an incredibly easy to use data structure and API's!  Although, perhaps more importantly,  Lexicomp is unparalleled in its customer service and providing assistance in the development process. If you are developing a new EMR and need a drug information supplier, make sure that Lexi is on your list.

Are you heavily involved in making the critical decisions for EMR development and the need to include the best drug information, along with the best vendor support?

Several weeks ago I wrote:

Are you the owner or manager of an ambulatory EMR company?   What keeps you up late at night?   Worried about getting your product to the market as quickly as possible and keeping your costs under control?  Worried about certification?   No doubt you have some thoughts about reducing medical errors by including the best drug information and internal built-in logic.   More and more EMR and EHR  business owners and general managers are turning to Lexicomp to solve their drug information needs.

In a few short years,  Lexicomp has been the fastest growing provider of drug information to the EMR market.  As I said in a previous post:

In addition to supplying the expected information such as drug-drug and drug-allergy interactions, adverse drug events, RxNorm mapping, generic drug lists, drug nomenclature, and more.  Lexi-Data offers an incredibly easy to use data structure and API's and most importantly,  Lexicomp is unparalleled in its customer service and providing assistance in the development process. If you are developing a new EMR and need a drug information supplier, make sure that Lexi is on your list.

And if you are thinking about building your own ePrescribing module,  I call your attention to a posting my colleague Matt Bennardo published last week:

As EHR vendors find their products growing and signing up more users, many start to think about moving from using a third-party eprescribing solution to building their own. The reasons for making this switch are many:

• As your user base grows, eprescribing fees grow too
• Bring features in-house makes it easier to respond to specific customer needs
• A third-party solution is a risk, as you never can be sure what will happen in the market

One of the first steps in building your own eprescriber is to find a data provider who can supply you with medication lists and other information that Surescripts requires to certify your tool. Lexicomp is one such provider. They've been focused on providing drug data direct to clinicians for over thirty years, but now they can also supply you with database-ready information to power an eprescriber.

Lexicomp's customers have used their data to certify EMRs and EHRs with ONC testing bodies like Drummond, CCHIT, and Infogard. Their customers have also certified eprescribers using Lexicomp data with Surescripts. And best of all, Lexicomp's flexible pricing and easy implementation allows firms of all sizes to get up and running smoothly and quickly.

Contact Lexicomp using the links on this page today for more information.

Why I am repeating a headline from last week and some similar content?  Because it seems to resonate with those folks who are making the critical decisions on their EMR development and their need to include the best drug information,  along with the best vendor support. 

As I wrote:

Are you the owner or manager of an ambulatory EMR company?   What keeps you up late at night?   Worried about getting your product to the market as quickly as possible and keeping your costs under control?  Worried about certification?   No doubt you have some thoughts about reducing medical errors by including the best drug information and internal built-in logic.   More and more EMR and EHR  business owners and general managers are turning to Lexicomp to solve their drug information needs.

In a few short years,  Lexicomp has been the fastest growing provider of drug information to the EMR market.  As I said in a previous post:

In addition to supplying the expected information such as drug-drug and drug-allergy interactions,  adverse drug events,  RxNorm mapping,  generic drug lists,  drug nomenclature,  and more.  Lexi-Data offers an incredibly easy to use data structure and API's and most importantly,  Lexicomp is unparalleled in its customer service and providing assistance in the development process. If you are developing a new EMR and need a drug information supplier, make sure that Lexi is on your list.

Some of my colleagues have asked me to re-post my blog from last week.  So I will do so.

Are you the owner or manager of an ambulatory EMR company?   What keeps you up late at night?   Worried about getting your product to the market as quickly as possible and keeping your costs under control?  Worried about certification?   No doubt you have some thoughts about reducing medical errors by including the best drug information and internal built in logic.   More and more EMR and EHR  business owners and general managers are turning to Lexicomp to solve their drug information needs.

In a few short years,  Lexicomp has been the fastest growing provider of drug information to the EMR market.  As I said in a previous post:

" In addition to supplying the expected information such as drug-drug and drug-allergy interactions,  adverse drug events,  RxNorm mapping,  generic drug lists,  drug nomenclature,  and more.  Lexi-Data offers an incredibly easy to use data structure and API's and most importantly,  Lexicomp is unparalleled in its customer service and providing assistance in the development process. If you are developing a new EMR and need a drug information supplier, make sure that Lexi is on your list.

Are you the owner or manager of an ambulatory EMR company?   What keeps you up late at night?   Worried about getting your product to the market as quickly as possible and keeping your costs under control?  Worried about certification?   No doubt you have some thoughts about reducing medical errors by including the best drug information and internal built in logic.   More and more EMR and EHR  business owners and general managers are turning to Lexicomp to solve their drug information needs.

In a few short years,  Lexicomp has been the fastest growing provider of drug information to the EMR market.  As I said in a previous post:

" In addition to supplying the expected information such as drug-drug and drug-allergy interactions,  adverse drug events,  RxNorm mapping,  generic drug lists,  drug nomenclature,  and more.  Lexi-Data offers an incredibly easy to use data structure and API's and most importantly,  Lexicomp is unparalleled in its customer service and providing assistance in the development process. If you are developing a new EMR and need a drug information supplier, make sure that Lexi is on your list."

I have had several comments asking for me to repeat several of my recent blog posts,  so here they are:

The first one:

"In a few short years,  Lexicomp has gone from being the provider of choice for drug reference information to the vendor of choice for EMR development companies looking for a supplier of drug data to include in their product.   Lexi-Data provides all of the standard drug information that one would expect from the other suppliers,  but it also provides the best pediatric dosing information available.   In addition to supplying the expected information such as drug-drug and drug-allergy interactions,  adverse drug events,  RxNorm mapping,  generic drug lists,  drug nomenclature,  and more.  Lexi-Data offers an incredibly easy to use data structure and API's and most importantly,  Lexicomp is unparalleled in its customer service and providing assistance in the development process. If you are developing a new EMR and need a drug information supplier, make sure that Lexi is on your list."

The second:  (enjoy)

"We live in a turbulent and fast changing world.  What was good yesterday is not necessarily what is best for today.   Where is Netscape?   How about Alta Vista?    Lotus is certainly history but how many of you remember Multiplan and before that VisiCalc?  The changes occur quickly -- not like the phasing out of a buggy whip. 

The same could  be said about more and more EMR developers who are turning to Lexi-Data for their drug information.    Lexi-Data just hit the scene a little more than two years ago.  And how quickly it has grown and capturing a major part of new EMR development in need of drug information.  Why so?

Is it about drug information quality?   Is it about ease of integrating the APIs?   How about quality of the Pediatric Drug Information and drug-drug and drug-allergy interactions?  Or is about the top quality customer support during the development and integration phase,  where Lexicomp treats it customers like true partners?"

Needless to say,  as you can imagine,  it is about all of the above.   If you haven't acted yet,  it is about time.

In a few short years,  Lexicomp has gone from being the provider of choice for drug reference information to the vendor of choice for EMR development companies looking for a supplier of drug data to include in their product.   Lexi-Data provides all of the standard drug information that one would expect from the other suppliers,  but it also provides the best pediatric dosing information available.   In addition to supplying the expected information such as drug-drug and drug-allergy interactions,  adverse drug events,  RxNorm mapping,  generic drug lists,  drug nomenclature,  and more.  Lexi-Data offers an incredibly easy to use data structure and API's and most importantly,  Lexicomp is unparalleled in its customer service and providing assistance in the development process. If you are developing a new EMR and need a drug information supplier, make sure that Lexi is on your list.

ePrescribing is offered as a way to prevent medication errors that arise due to difficulties in reading or understanding handwritten prescriptions. ePrescribing could also reduce adverse drug events (ADEs) by making information such as drug interactions and contraindications available to prescribers at the time they are preparing a prescription.

Lexi-Data is the foundation of Lexicomp's clinical decision support architecture is quickly becoming the standard for when companies need an up-to-date comprehensive drug database.  This product provides patient specific alerts and referential content to support sound treatment decisions in areas such as drug interaction checking (drug-drug and drug-food), drug allergy checking, therapeutic duplication checking, RxNorm Mappings, supports Surescripts Certification,  Drug Classifications, dose range checking (adult and pediatric), Patient Education, and more. 

As Matt Bennardo pointed out, when EMR and EHR companies are under development and they are looking to include drug and medicine information, they must given proper consideration to the quality of the drug information, the ease of installation, and the level of customer service provided by the drug  data provider.  In order to meet the Meaningful Use standards,  the EMR and EHR developers now care more about drug and medicine information than ever before.   They now care about drug interactions,  drug-drug and drug-allergy interactions,  adverse drug events,  patient education pamphlets,  dose information,  pediatric dosing inforamation,  drug brand names and drug generic names.

Hundreds of Lexi-Data customers are now integrating Lexicomp reference and transaction drug information into their systems under development.   As Matt had said:

"Comprehensive data covers all decision support Meaningful Use requirements:

• Compatible with required standards like RxNorm
• Supports drug-drug and drug-allergy interaction checking
• All data necessary for ePrescribing and CPOE
• Additional functionality like dose range checking

Fastest and easiest integration gets you to market faster:

• Easy-to-use APIs and web services -- you choose which you want
• Superior one-on-one customer service
• Most intuitive data structure and fastest implementation

New features set you apart from the competition:

• Black Box Warning filters to alleviate clinician alert fatigue
• Patient education available in 19 languages

Click the links on this page to find out more about Lexi-Data now!"

Anyone who has been exposed to electronic order entry has experienced the dreaded "alert fatigue".  If the goal of electronic prescribing is to improve patient safety and outcomes, alerting clinicians to potential drug interactions or other dosing precautions is necessary.  In our current information age, there is a plethora of information available regarding medication safety and potential safety issues with the use of medications.  In an attempt to help clinicians sift through all this information, the FDA has established the use of a "Black Box Warning" to call attention to the most important safety issues.  A recent study published in the Archives of Internal Medicine reviewed several drug information providers comparing their ability to identify black box warnings and confirmed that Lexicomp is the leader in this area.
 
In an effort to incorporate this valuable information into the clinician's busy workflow, Lexcomp has recently enhanced their Lexi-Data product to include Black Box Warnings.  The Black Box Warnings table allows system vendors to present critical medication safety information from these warnings within a health information system.  The data is also structured in a way that will allow the system vendors to filter which alerts are presented, allowing for instance a prescriber to see warning specific to the ordering process and a pharmacist seeing warnings more relevant to the dispensing process.

Improving patient safety requires the use of "intelligent alerting", Lexi-Data has given system vendors the ability to present critical safety information in a meaningful way. 

Medication errors and adverse drug events are serious issues in healthcare.  Apprx 770,000 injuries or deaths related occur each year.  For this reason and to comply with the certification and meaningful use requirements, every EMR should look at partnering with and providing their customers top rated drug interaction, duplicate therapy, allergy and dose range checking information integrated into their EMR.  Lexicomp and the Lexi-Data product can offer this solution. 

This information and its quality, customizability, and delivery format can really set your EMR apart from the competition.  In 2010 the EMR market grew by almost 13.5% while competition in this area is also growing at a higher than predicted rate.  More and more physicians are now starting to look at implementation of an EMR although the rate of adoption has been slowed by the complicated maze of meaningful use.  None the less, it is critical that EMRs differentiate and help physicians understand how to navigate through this maze.   Drug Data Vendors that are able to offer what others may not can help these EMR companies win more deals.  Drug interactions that are cusomizable, dose range checking for specific populations (adult, pediatric, geriatric) duplicate therapy checking and an overall solid patient education offering are areas that can be easily implemeted from Lexi-Data.  Lexicomp's expertise and customer service can also help get you up and running fast.  The database is easy to work with, available in mutliple formats and even has a web-service set can help start up and established EMRs build the structure needed to help physicians.

For more information visit www.lexi.com/businesses/ehr-vendors/

Does your EHR or patient portal include patient education pamphlets? If so, how confident are you that patients receiving the materials get the information they need? For many patients, the problem may be as basic as not understanding the language that the documents are written in.

Lexicomp is a recognized leader in patient education. Their leaflets are used in over a thousand hospitals in the U.S. and Canada. Not only are the leaflets available in 19 common languages, but they are tailored specifically to adult and pediatric patients as well. There can be huge differences in dosing, warnings, and possible adverse drug events among these populations.

Lexicomp's patient education is available for integration into a wide variety of systems -- including EHRs, EMRs, HIS systems, ePrescribing systems, patient portals, consumer websites, PMSs, and more. Contact them today using the links on this page for more information!

One difficult aspect of drug nomenclature is the complexity of drug concepts. Clinicians speak fluidly about these concepts, flowing from class-based terminology (penicillins) to individual drugs (penicillin) with ease. But drug classifications are not well standardized, and some systems blend pharmacologic concepts with chemical concepts. For example, consider a system which uses "beta-adrenergic receptor blockers" and "fluoroquinolones". One speaks to the pharmacologic target while the other refers to a shared chemical composition. Clinicians understand and interpret these differences, but electronic applications have more difficulty. RxNorm is an effort to standardize these naming conventions for an individual drug. These concepts are generally included in proprietary vocabularies, but there is little consensus among them. These may complicate efforts to establish comparisons on adverse drug events, allergy, and other comparative features among members of a class. Class level groupings are included in SnoMed and may provide a basis of standardization. For this reason efforts to standardize to a single class nomenclature are important and necessary.

It is estimated that each year some 530,000 adverse drug events take place among Medicare beneficiaries alone because of drugs negatively interacting with other drugs the patient is already taking, or insufficient information about the patient’s medical history.  The Institute of Medicine (IOM) reported last year that more than 1.5 million Americans are injured annually by drug errors in hospitals, nursing homes and doctor’s offices.  These negative drug events may require costly interventions in order to stabilize the patient, including hospitalization.  

Nothing is final yet, but in all likelihood Meaningful Use Stage 2 won't kick in until 2014. In addition, some of the draft recommendations floating around look a lot like Stage 1 with stricter compliance levels. In other words: much of the work for Stage 2 is going to fall on EPs and hospitals, rather than on EMR vendors. There will likely be some new functionality -- especially around provider-patient communication -- but probably not the crush of requirements we saw in Stage 1.

So what will EMR, EHR, and HIS vendors do with their reprieve? If they're smart, they'll take this opportunity to improve their products in ways that aren't (yet!) required by Meaningful Use but which will give them an advantage in the market. Here's some functionality that EMRs may be using this reprieve to pursue:

• Implementing dose range checking: From a clinical point of view, this is one of the big gaps in what we've seen so far in the first two stages of Meaningful Use. Many of the news stories we read about adverse drug events aren't about interactions or allergies at all -- they're about mistakes in dosing. This is especially true with pediatric dosing, which can be extremely complicated. If dosage precautions were more widely implemented, patient safety would be positively affected.
• Addressing alert fatigue: Many EMR systems are likely to live or die based on this issue alone. Whoever can figure it out will have an undeniable benefit over the competition. As with many Meaningful Use issues, it starts with drug information vendors -- does yours provide the detail needed to make alerts intelligent?
• Improving patient education: The new recommendations for Stage 2 Meaningful Use are all about provider-patient communication. And transcripts of workgroups show that CMS and ONC are very interested in improving not just the method of communication, but the quality of information that flows through it. It seems likely that this will eventually include things like specific patient education materials for pediatric and adult patients, delivered in the language they primarily speak.

EMR vendors that can solve some or all of these issues now will find themselves ahead of the game when the next round of MU guidelines come out. Not only that, but they'll be delivering real value to clinicians that sets them apart from all the other cookie-cutter competitors who are simply "checking boxes" on the Meaningful Use checklist.

But where to start? Lexicomp is a drug and clinical information vendor who can help with all of the items listed above -- and with many more as well. Call or fill out a form today to start learning about how Lexicomp can help you build value for your users, save money and development resources, and meet government requirements for your EMR system.

A recent JAMIA study by Bates et al. noted that the strongest factor influencing acceptance of alerts from drug interaction software is the presentation. This was found to have a stronger association than factors such as the setting or level of the alert. In an electronic prescribing environment, there is much concern about alert fatigue. Drug data vendors are often the targets of frustration of clinicians, and there is a reasonable criticism regarding the ability to have more consistency in alerting, the ability to filter to the user, and suppression of "truthful but not useful" alerts. Considering the role these alerts play in preventing adverse drug events, it would seem that at least as much attention should be paid to the way the alerts are delivered.